X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (158) 158
hematology (95) 95
middle aged (95) 95
aged (92) 92
female (82) 82
male (80) 80
oncology (78) 78
index medicus (68) 68
adult (51) 51
aged, 80 and over (51) 51
medicin och hälsovetenskap (49) 49
medical and health sciences (45) 45
cancer (37) 37
leukemia, lymphocytic, chronic, b-cell - drug therapy (36) 36
klinisk medicin (27) 27
alemtuzumab (25) 25
antibodies, monoclonal - therapeutic use (25) 25
therapy (25) 25
clinical medicine (24) 24
leukemia, lymphocytic, chronic, b-cell - immunology (24) 24
multiple myeloma (24) 24
chemotherapy (23) 23
t cells (23) 23
treatment outcome (23) 23
immunotherapy (22) 22
leukemia (22) 22
t-lymphocytes - immunology (22) 22
antineoplastic agents - therapeutic use (21) 21
chronic lymphocytic-leukemia (21) 21
cll (21) 21
medicine (21) 21
survival (21) 21
chronic lymphocytic leukemia (20) 20
rituximab (20) 20
expression (19) 19
multiple myeloma - drug therapy (19) 19
immunology (18) 18
leukemia, lymphocytic, chronic, b-cell - pathology (18) 18
cancer och onkologi (17) 17
fludarabine (17) 17
anemia - drug therapy (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
hematology, oncology and palliative medicine (16) 16
medicin (16) 16
animals (15) 15
apoptosis (15) 15
flow cytometry (15) 15
lymphoma (15) 15
multiple myeloma - immunology (15) 15
antibodies, monoclonal, humanized (14) 14
cancer and oncology (14) 14
care and treatment (14) 14
hematologi (14) 14
lymphomas (14) 14
medicine & public health (14) 14
analysis (13) 13
antibodies, monoclonal - adverse effects (13) 13
antineoplastic agents - adverse effects (13) 13
dendritic cells (13) 13
non-hodgkins-lymphoma (13) 13
pathology (13) 13
proteins (13) 13
vaccination (13) 13
b-cells (12) 12
cell line, tumor (12) 12
chronic lymphocytic leukaemia (12) 12
erythropoietin - therapeutic use (12) 12
follow-up studies (12) 12
gene expression (12) 12
multiple myeloma - pathology (12) 12
multiple-myeloma (12) 12
reverse transcriptase polymerase chain reaction (12) 12
anemia (11) 11
case-control studies (11) 11
cyclophosphamide (11) 11
drug resistance, neoplasm (11) 11
erythropoietin (11) 11
ibrutinib (11) 11
leukemia, lymphocytic, chronic, b-cell - genetics (11) 11
leukemia, lymphocytic, chronic, b-cell - metabolism (11) 11
multiple myeloma - metabolism (11) 11
trial (11) 11
tumor cells, cultured (11) 11
activation (10) 10
antibodies (10) 10
antibodies, neoplasm - therapeutic use (10) 10
b-cll (10) 10
chronic lymphatic leukemia (10) 10
disease progression (10) 10
double-blind (10) 10
health aspects (10) 10
leukemia, lymphocytic, chronic, b-cell - mortality (10) 10
phenotype (10) 10
prognosis (10) 10
t-cells (10) 10
vidarabine - analogs & derivatives (10) 10
antibodies, monoclonal - administration & dosage (9) 9
b-lymphocytes - immunology (9) 9
bone-marrow (9) 9
campath-1h (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1013 - 1022
Journal Article
Journal Article
Cancers, ISSN 2072-6694, 06/2019, Volume 11, Issue 7, p. 915
In lymphomas of B-cell origin, cancer cells orchestrate an inflammatory microenvironment of immune and stromal cells that sustain the tumor cell survival and... 
macrophages | PD-L1 | immune cells | tumor microenvironment | CD47 | T cells | PD-1 | B-cell lymphoma | Hodgkin lymphoma
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0198038
There is a great unmet medical need in pancreatic carcinoma (PC) for novel drugs with other mechanisms of action than existing. PC cells express the onco-fetal... 
GROWTH-FACTOR RECEPTOR | MODELS | PATHWAY | MULTIDISCIPLINARY SCIENCES | CHRONIC LYMPHOCYTIC-LEUKEMIA | CANCER | GEMCITABINE | LINES | Apoptosis - drug effects | Receptor Tyrosine Kinase-like Orphan Receptors - metabolism | Humans | Pancreatic Neoplasms - pathology | Pancreas - drug effects | Pancreas - pathology | Pyrimidines - pharmacology | Low Density Lipoprotein Receptor-Related Protein-6 - chemistry | Drug Synergism | Receptor Tyrosine Kinase-like Orphan Receptors - antagonists & inhibitors | Receptor Tyrosine Kinase-like Orphan Receptors - chemistry | Erlotinib Hydrochloride - pharmacology | Organic Chemicals - pharmacology | Protein Structure, Quaternary | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Protein Multimerization - drug effects | Pyrazoles - pharmacology | Care and treatment | Enzyme inhibitors | Erlotinib | Pancreatic cancer | Oncology, Experimental | Dosage and administration | Research | Health aspects | Apoptosis | Cancer | Cell proliferation | Biotechnology | Phosphorylation | Wnt protein | Gemcitabine | Clinical trials | Oncology | Metastasis | Kinases | Cancer therapies | Metastases | Cell growth | Epidermal growth factor | Pancreatic carcinoma | Protein-tyrosine kinase receptors | Protein-tyrosine kinase | Tyrosine | Medical research | Cell survival | Hematology | Tumor cells | Fetuses | Breast cancer | Molecular chains | Pathology | Inhibitors | Cell death | Cell lines | Monoclonal antibodies | Pheochromocytoma cells | Gene therapy | Binding sites | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, p. e78339
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2012, Volume 30, Issue 25, pp. 3093 - 3099
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 1/2017, Volume 66, Issue 1, pp. 91 - 102
Journal Article
Journal Article